C4 Therapeutics, Inc. (CCCC) — Analysis Summary
C4 Therapeutics, Inc. (CCCC) has a market cap of $483.18M with year-over-year revenue growth of +1.0%. Net margin stands at -292.1%. The stock trades at a P/E ratio of -4.7.
Key Takeaways
- Revenue changed +1.0% year-over-year
- Net margin of -292.1%
- P/E ratio of -4.7
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, CCCC posted revenue growth of +1.0% and trades at a P/E of -4.7.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.